Citadel Advisors’s Wearable Devices WLDS Stock Holding History

Citadel Advisors’s Portfolio WLDS Stock Details WLDS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$40.4K	Buy	+24,471	New	+$74K	﹤0.01%	13217
2024 Q4	–	Sell	-147	Closed	-$24.6K	–	15482
2024 Q3	$24.6K	Sell	147 -103	-41%	-$28.4K	﹤0.01%	12614
2024 Q2	$104K	Buy	+250	New	+$76.8K	﹤0.01%	10859
2023 Q4	–	Sell	-82	Closed	-$46.2K	–	15363
2023 Q3	$46.2K	Buy	+82	New	+$72.8K	﹤0.01%	11840
2023 Q2	–	Sell	-18	Closed	-$6.57K	–	15326
2023 Q1	$6.57K	Buy	+18	New	+$8.09K	﹤0.01%	13796

Other funds holding WLDS

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

Virtu Financial New York $3.18B AUM 65.92% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

WAM

Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return

Citadel Advisors's WLDS Position: Q2 2026 in Review

Citadel Advisors opened a new position in Wearable Devices (WLDS) in Q2 2026: 24,471 shares worth $40.4K. The stake represents ﹤0.01% of the portfolio and ranks #13217 among its holdings. This is a return to the name: Citadel Advisors previously reported a position in WLDS as recently as Q3 2024.

Citadel Advisors first reported a position in WLDS in Q1 2023 and has held it in 5 quarters since. The position peaked at $104K in Q2 2024. 6 funds tracked by Wall St. Rank hold WLDS as of Q2 2026.

Citadel Advisors held 24,471 shares of Wearable Devices worth $40.4K as of Q2 2026.
Wearable Devices was a new Citadel Advisors position in Q2 2026.
Wearable Devices made up ﹤0.01% of Citadel Advisors's portfolio in Q2 2026, its #13217 holding.
Citadel Advisors first reported a position in Wearable Devices in Q1 2023 and has held it in 5 quarters since.
Citadel Advisors's Wearable Devices position peaked at $104K in Q2 2024.
6 funds tracked by Wall St. Rank held Wearable Devices as of Q2 2026.

Based on Citadel Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.